Propanc Biopharma, Inc. (PPCB) stock
PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30
$1.94+0.02 (+1.09%)
Close on Nov 13, 2026Market cap $12.29MP/E –Yield –
Propanc Biopharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Propanc Biopharma's enterprise value was $5.26M on Nov 11, 2026, against $285.50M a year earlier. Over the last 5 years it ranged from -$71.62K to $29.00B, with a median of $421.98K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.26M | -96.9% |
| 2025 | Dec 31, 2025 | $171.20M | – |
| 2024 | Dec 31, 2024 | -$9.15K | – |
| 2023 | Dec 29, 2023 | -$6.48K | -102.0% |
| 2022 | Dec 30, 2022 | $319.27K | -79.6% |
| 2021 | Dec 31, 2021 | $1.56M | +99.3% |
| 2020 | Dec 31, 2020 | $783.88K | – |
| 2019 | Dec 31, 2019 | -$94.22K | – |
| 2018 | Dec 31, 2018 | -$38.88K | – |
See a number that looks wrong?